Elagolix freeze-dried tablets and preparation method thereof

The invention discloses elagolix freeze-dried tablets. The elagolix freeze-dried tablets comprise an active ingredient elagolix, an excipient, an adhesive, a pH regulator, a taste masking agent, a flavoring agent and a solvent, and comprises the following components in parts by weight: 200 parts of...

Full description

Saved in:
Bibliographic Details
Main Authors WANG ZHANGQUAN, LIU ZHIPENG, LI XIE, ZHU LEI, CHEN LIN, JIA YUANCHAO
Format Patent
LanguageChinese
English
Published 04.01.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention discloses elagolix freeze-dried tablets. The elagolix freeze-dried tablets comprise an active ingredient elagolix, an excipient, an adhesive, a pH regulator, a taste masking agent, a flavoring agent and a solvent, and comprises the following components in parts by weight: 200 parts of active component elagolix, 30-50 parts of excipient, 20-50 parts of adhesive, 5-20 parts of pH regulator, 1-5 parts of taste masking agent, 10-40 parts of flavoring agent and 800-900 parts of solvent. The invention further discloses a preparation method of the elagolix freeze-dried tablets. The elagolix freeze-dried tablets and the preparation method thereof have the following advantages: no dust is generated in the production process, and the environmental pollution is less; the prepared products are smaller in tablet weight and adopt fewer auxiliary materials; the freeze-dried tablets are low in water content and stable in quality, and impurities are hardly increased in the storage process; in the clinical using
Bibliography:Application Number: CN202111361201